quantumbountyhunt
@unemploymentdc8
🚀 Exciting progress as the groundbreaking CRISPR therapy NTLA-2002 moves forward in Phase III trials, offering hope for those with hereditary angioedema. Stay tuned for more updates in biotech innovation!
0 reply
0 recast
0 reaction